HABU Daiki


Search Institutional Repository



Laboratory location

Sugimoto Campus

Degree 【 display / non-display

  •  -  Doctor of Medicine

Research Areas 【 display / non-display

Gastroenterology, Hepatology, Abdominal ultrasonics

Research Career 【 display / non-display

  • Nutritive treatment for chronic liver disease


Current Career 【 display / non-display

  • Osaka City University   Graduate School of Human Life Science   Human Life Science Course   Professor  

Graduate School 【 display / non-display


    Osaka City University  Others 

Graduating School 【 display / non-display


    Nara Medical University   Faculty of Medicine  


Published Papers 【 display / non-display

  • Validation of the method of evaluation of the official Japanese report of the Nutrition Support Team (NST) with respect to the outcome of the NST in an acute hospital

    Endo Takayuki, Yamaoka Minori, Hatino Saki, Iwatani Satoshi, Momoki Chika, Habu Daiki

    The Japan Dietetic Association, Journal of the Japan Dietetic Association  60 ( 8 ) 449 - 455 2017  [Refereed]

     View Summary

    <p>We validated the evaluation method of the official Japanese report of the Nutrition Support Team (NST) for the outcome of NST in an acute hospital and analyzed factors relevant to the outcome of NST. We identified the specific items corresponding to the each particles of NST outcome measurement. We then compared the objective nutritional date of the good responder group (GR) and the poor responder group (PR) for the NST intervention. <br/>We classified the main interventional methods into 4 types: modification of food supply, enteral nutrition, parenteral nutrition, and drug administration. Subsequently, we analyzed the efficacy of these methods as NST interventional tools. <br/>At enrollment, serum albumin (Alb), hemoglobin (Hb), and transthyretin (TTR) levels and the prognostic nutritional index (PNI) of the GR were significantly lower than those of the PR. After NST interventions, Alb, TTR, and Hb levels and PNI of the GR significantly improved. Enteral nutrition and modification of food supply could improve the energy sufficiency rate and the balance of energy intake of the study subjects. <br/>The method of evaluation of the official Japanese report of the NST with respect to the outcome of the NST might be useful to some extent. Enteral nutrition and modification of food supply were useful in NST interventions.</p>

    DOI CiNii

  • Lifestyle characteristics of rheumatoid arthritis patients with sarcopenia

    Matsumoto Yoshinari, Sugioka Yuko, Tada Masahiro, Okano Tadashi, Mamoto Kenji, Inui Kentaro, Habu Daiki, Koike Tatsuya

    Japanese Society for Parenteral and Enteral Nutrition, JJSPEN  30 ( 3 ) 793 - 797 2015  [Refereed]

     View Summary

    <b>Objective:</b> To clarify lifestyle characteristics of rheumatoid arthritis (RA) patients with sarcopenia. <br><b>Subjects and Methods:</b> A total of 208 consecutive RA outpatients were assessed. Skeletal muscle mass was measured by dual energy x-ray absorptiometry (DXA). The criterion of sarcopenia was defined as a low skeletal muscle index (appendicular muscle mass/height<sup>2</sup> , kg/m<sup>2</sup>; men, ≤6.87 kg/m<sup>2</sup>; women, ≤5.46 kg/m<sup>2</sup>; reference population, Japanese young adults aged 18-40 years). Brief-type self-administered diet history questionnaire (BDHQ) was used for investigation of the intake of energy, nutrients and food. <br><b>Results:</b> In RA patients, the sarcopenia group showed significantly higher disease activity and lower activity of daily living (ADL) compared to those in the non-sarcopenia group. In addition, a greater number of patients in the sarcopenia group had exercise restrictions than in the non-sarcopenia group. Calcium intake had a tendency to be lower, and intake of milk and other dairy products was significantly lower, in the sarcopenia group than in the non-sarcopenia group.<br><b>Conclusion:</b> Exercise restriction, low ADL, and low intake of milk and other dairy products were determined to be the lifestyle characteristics of RA patients with sarcopenia.

    DOI CiNii

  • Relationship Between of Bright Pancreas With Fatty Liver and Ischemic Heart Disease

    Komiyama Yasuhiro

    Japanese Society of Sonographers, Japanese Journal of Medical Ultrasound Technology  40 ( 3 ) 295 - 303 2015  [Refereed]

     View Summary

    We focus on the bright pancreas, with fat accumulation in the pancreas, and evaluated the brightness by histogram values. The difference in brightness between pancreas and spleen was indicated as &ldquo;pancreas-spleen difference&rdquo; and was measured by abdominal ultrasonography. The risk of ischemic heart disease based on this pancreas-spleen difference was verified.<br> Nineteen-patients which showed symptoms of coronary artery disease were used for a case-control study with 36 patients who had come to the hospital for a thorough physical check. Patients were matched for age and sex. The pancreas-spleen difference of the ischemic-heart-disease group was significant. A multivariate analysis conducted by using known risk factors for the onset of ischemic heart disease, such as obesity, smoking, and drinking, showed the importance of the pancreas-spleen contrast difference.<br> By using the screening method which added not only the liver, but the brightness elevation view of the pancreas, it became clear that brightness was the independent affector, with a high possibility for showing symptoms of ischemic heart disease.

    DOI CiNii

  • Fatty liver with ultrasonographic bright pancreas may have higher affinity for metabolic syndrome

    KOMIYAMA Yasuhiro, MOMOKI Chika, HABU Daiki, MORI Takahiro, ITO Tadashi, SHIMIZU Seiji, MIZUNO Shigeto

    The Japanese Society of Gastrointestinal Cancer Screening, Nihon Shoukaki Gan Kenshin Gakkai zasshi  52 ( 1 ) 61 - 69 2014  [Refereed]

     View Summary

    (Objective) The most frequently observed abnormality in abdominal ultrasonography is fatty liver. However, it is difficult to conduct thorough examination in all patients with fatty liver. In recent years, fat accumulation in the pancreas has attracted attention as a risk factor of arteriosclerotic disease. In this study, we focused on the degree of fat accumulation in the pancreas for the purpose of extracting fatty livers with a greater risk of arteriosclerosis. <BR>(Subjective and Methods) One hundred and twenty one patients with fatty liver were investigated. As an index to show the degree of fat accumulation in the pancreas, brightness was evaluated by histogram values and the difference in brightness between the pancreas and spleen was indicated as the &ldquo;pancreas-spleen difference.&rdquo; <BR>(Results) In patients with fatty liver, receiver operating characteristic analysis (ROC) was performed for the pancreas-spleen difference with the presence or absence of concurrent metabolic syndrome as the outcome, and the pancreas-spleen difference cutoff value was set at 45. It resulted in moderate accuracy with sensitivity of 0.652, specificity of 0.702, and area under the curve (AUC) of 0.705. The patients in the group with a high pancreas-spleen difference had concurrent metabolic syndrome at a higher frequency and had higher values of visceral fat area, higher body weight, higher BMI and higher abdominal circumference, suggesting that it is a group of patients with fatty liver with a greater risk of arteriosclerosis. <BR>(Conclusion) It was indicated that adding the pancreas-spleen difference to the ultrasonic screening test could extract types of fatty livers that have high affinity for metabolic syndrome.

    DOI CiNii

  • Perioperative exercise with branched-chain amino acid for chronic liver injury patients with hepatocellular carcinoma undergoing hepatectomy

    KAIBORI Masaki, NISHIKIDO Kiminari, MATSUI Kosuke, ISHIZAKI Morihiko, NAKATAKE Richi, SAKAGUCHI Tatsuma, MATSUSHIMA Hideyuki, YOSHIUCHI Sawako, MIYAUCHI Takumi, SAITA Akane, OHKITA Sayuri, KIMURA Yutaka, HABU Daiki, KWON A-Hon

    35 ( 2 ) 210 - 217 2013.04  [Refereed]


display all >>

Review Papers (Misc) 【 display / non-display

  • Calcitriol for bone loss in patients with primary biliary cirrhosis

    Gastroenterol  34   241 - 245 1999

  • Clinical usefulness of conjugated bilirnbin levels in patients with acute liver disease

    J. Gastroenterol  34   88 - 93 1999

  • Longitudinal changes with age in bone mineral density of patients with primary biliary cirrhosis

    Hepatology Research  10   49 - 57 1998